Paul Calabresis Career Development Award For Clinical Oncology

保罗·卡拉布雷西斯临床肿瘤学职业发展奖

基本信息

批准号：
8134997
负责人：
ROMAN PEREZ-SOLER
金额：
$ 113.4万
依托单位：
ALBERT EINSTEIN COLLEGE OF MEDICINE
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-09-29 至 2014-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8134997
关键词：
Advisory Committees Albert Einstein Cancer Center Cancer Research Project Clinical Clinical Investigator Clinical Oncology Clinical Research Commit County Educational process of instructing Foundations Funding Genetic Medicine Grant Institutes Institution Instruction Investigation K-Series Research Career Programs Leadership Malignant Neoplasms Medical center Medicine Mentors Mission Monitor NCI Scholars Program Population Principal Investigator Qualifying Quality of Care Research Research Activity Research Personnel Research Support Research Training Resources SECTM1 gene Therapeutic Training Training Programs Translational Research Underrepresented Minority Underserved Population United States National Institutes of Health Work anticancer research base cancer research center director career college experience interdisciplinary collaboration member patient oriented professor programs racial and ethnic research facility translational medicine

项目摘要

DESCRIPTION (provided by applicant): This proposal seeks to support and develop junior clinical investigators in therapeutic cancer research at the Albert Einstein College of Medicine, through a coordinated program of mentoring, didactic course work, collegial interdisciplinary collaboration, and research support. The leadership for this program is integrated with the Albert Einstein Cancer Center (AECC) and Einstein's Institute for Clinical and Translational Research (ICTR), and based on the major commitment of the Institution to the training and mentoring of young clinical investigators. This Paul Calabresi Scholars Program will select highly qualified clinical and translational investigators, including both MDs and PhDs, each developing their careers in patient-oriented clinical and translational research in cancer therapeutics. Didactic course work will be provided through the K30 and other programs, as needed, with an individualized course of instruction determined for each Scholar. Program oversight will be provided by the Principal Investigator, Dr. Roman Perez-Soler, Professor of Medicine and Associate Director for Clinical Research at the AECC. They will be assisted by an Advisory Committee of leaders of Einstein's cancer research programs, who will select Scholars and monitor each Scholar's progress, and a group of External Advisors formed by PI's of Calabresi Grants at other institutions. The Albert Einstein College of Medicine is ideally suited to implement this program. With its strong foundation in NIH supported investigation, it has invested heavily in building its clinical and translational research activities in cancer under the leadership of the AECC Director, Dr. David Goldman. The PI of this KI2 proposal will assist Dr. Goldman in this mission. Einstein's new Dean, Dr. Allen Spiegel, is deeply committed to clinical and translational investigation; as underscored by a comprehensive new Strategic Research Plan and the recent completion of a new research facility, the Center for Genetic and Translational Medicine. Einstein has an outstanding base of clinical and research training programs in cancer, which will provide a pool of highly qualified candidates for this program. Our primary clinical affiliate, Montefiore Medical Center, provides high quality care to a large, traditionally underserved population in the Bronx, a county of over 1.3 million residents, over 80% of whom are members of ethnic/racial underserved minorities. Given its unique combination of clinical and scientific resources, population diversity, research funding, talented trainees, experienced mentors, teaching programs, research facilities, and institutional commitment, Einstein is poised to succeed in this K12 effort.

描述（由申请人提供）：该提案旨在通过指导、教学课程工作、学院跨学科合作和研究支持的协调计划，支持和培养阿尔伯特·爱因斯坦医学院治疗性癌症研究的初级临床研究人员。该项目的领导层与阿尔伯特·爱因斯坦癌症中心 (AECC) 和爱因斯坦临床与转化研究所 (ICTR) 整合，并基于该机构对年轻临床研究人员的培训和指导的主要承诺。该保罗·卡拉布雷西学者计划将选择高素质的临床和转化研究人员，包括医学博士和博士，每个人都在癌症治疗领域以患者为导向的临床和转化研究中发展自己的职业生涯。教学课程将根据需要通过 K30 和其他项目提供，并为每位学者确定个性化的教学课程。项目监督将由首席研究员、AECC 医学教授兼临床研究副主任 Roman Perez-Soler 博士负责。他们将得到由爱因斯坦癌症研究项目领导者组成的咨询委员会的协助，该委员会将选择学者并监督每位学者的进展，以及由其他机构的卡拉布雷西资助项目的 PI 组成的外部顾问小组。阿尔伯特·爱因斯坦医学院非常适合实施该计划。凭借 NIH 支持的调查的坚实基础，在 AECC 主任 David Goldman 博士的领导下，它投入巨资建设癌症临床和转化研究活动。 KI2 提案的 PI 将协助 Goldman 博士完成这项任务。爱因斯坦的新任院长艾伦·斯皮格尔博士致力于临床和转化研究。正如一项全面的新战略研究计划和最近建成的新研究设施——遗传与转化医学中心所强调的那样。爱因斯坦拥有出色的癌症临床和研究培训项目基础，这将为该项目提供一批高素质的候选人。我们的主要临床附属机构蒙蒂菲奥里医疗中心 (Montefiore Medical Center) 为布朗克斯区一大批传统上服务水平低下的人群提供高质量的护理，布朗克斯县拥有超过 130 万居民，其中 80% 以上是服务水平低下的少数族裔/种族成员。鉴于其临床和科学资源、人口多样性、研究经费、才华横溢的学员、经验丰富的导师、教学计划、研究设施和机构承诺的独特组合，爱因斯坦有望在 K12 努力中取得成功。